Literature DB >> 15517632

Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.

Der-Yuan Chen1, Joung-Liang Lan, Fang-Ju Lin, Tsu-Yi Hsieh.   

Abstract

OBJECTIVE: To investigate concentrations of proinflammatory cytokines in the sera and their mRNA expression in biopsy specimens of evanescent rash and synovitis from patients with active untreated adult onset Still's disease (AOSD).
METHODS: We measured serum levels of interleukin 6 (IL-6), IL-8, and tumor necrosis factor (TNF-alpha) by immunochemiluminescence method and serum IL-18 levels by ELISA in 50 patients with active untreated AOSD, 20 patients with active rheumatoid arthritis (RA), and 20 healthy controls. Multivariate analysis was used to evaluate the correlation between serum cytokine levels and disease activity and clinical features of AOSD. We also evaluated the expression of cytokine transcripts by real-time quantitative polymerase chain reaction in biopsy specimens of evanescent rash and synovitis from 12 patients with active untreated AOSD.
RESULTS: Significantly higher levels of IL-6, IL-8, IL-18, and TNF-alpha in sera were found in patients with active untreated AOSD compared to healthy controls. Serum levels of IL-6 and IL-18 correlated well with clinical activity score of AOSD patients. Multiple logistic regression analysis showed that serum IL-6 level was a possible predictor for the occurrence of evanescent rash (p = 0.0593), serum IL-8 level was a significant predictor of persistent arthritis, and serum IL-18 level predicted occurrence of liver dysfunction. The levels of mRNA expression of IL-6, IL-18, and IL-8 were significantly higher in the biopsy tissue of Still's rash from AOSD patients compared with those in controls. Levels of mRNA expression of IL-18, IL-8, and TNF-alpha were significantly higher in the synovial membranes of AOSD patients compared with those in osteoarthritis controls. Significantly lower levels of TNF-alpha and IL-8 were found in the sera and in the synovial membranes of AOSD patients compared with those in RA patients. AOSD patients who had a chronic articular course had significantly higher levels of serum IL-8 compared with those who had a monocyclic systemic course.
CONCLUSION: Significantly higher levels of IL-6, IL-8, IL-18, and TNF-alpha were seen in both sera and pathological tissues of patients with active AOSD. The associations between levels of cytokine profile and distinct clinical manifestations and various patterns of disease course suggest the heterogeneity of pathogenesis in AOSD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517632

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  75 in total

1.  The CD68(+)/H-ferritin(+) cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: correlation with disease severity and implication for pathogenesis.

Authors:  P Ruscitti; F Ciccia; P Cipriani; G Guggino; P Di Benedetto; A Rizzo; V Liakouli; O Berardicurti; F Carubbi; G Triolo; R Giacomelli
Journal:  Clin Exp Immunol       Date:  2015-12-08       Impact factor: 4.330

2.  Elevated levels of soluble Fas (APO-1, CD95), soluble Fas ligand, and matrix metalloproteinase-3 in sera from patients with active untreated adult onset Still's disease.

Authors:  Der-Yuan Chen; Joung-Liang Lan; Fang-Ju Lin; Tsu-Yi Hsieh
Journal:  Clin Rheumatol       Date:  2006-09-14       Impact factor: 2.980

3.  Successful treatment of refractory adult onset Still's disease with rituximab.

Authors:  K Ahmadi-Simab; P Lamprecht; C Jankowiak; W L Gross
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

4.  Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.

Authors:  Yue Sun; Zhihong Wang; Huihui Chi; Qiongyi Hu; Junna Ye; Honglei Liu; Xiaobing Cheng; Hui Shi; Zhuochao Zhou; Jialin Teng; Chengde Yang; Yutong Su
Journal:  Clin Rheumatol       Date:  2019-06-21       Impact factor: 2.980

Review 5.  Adult-Onset Still's Disease: Molecular Pathophysiology and Therapeutic Advances.

Authors:  Paolo Sfriso; Sara Bindoli; Paola Galozzi
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

Review 6.  Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Authors:  Ryota Sakai; Hayato Nagasawa; Eiko Nishi; Ayumi Okuyama; Hirofumi Takei; Takahiko Kurasawa; Tsuneo Kondo; Koji Nishimura; Yuichiro Shirai; Tatsuya Ito; Hideto Kameda; Tsutomu Takeuchi; Koichi Amano
Journal:  Clin Rheumatol       Date:  2012-01-04       Impact factor: 2.980

7.  Adult-Onset Still's Disease: A Case Report.

Authors:  Ong Ping Seung; Wahinuddin Sulaiman
Journal:  Oman Med J       Date:  2011-09

Review 8.  Adult-onset Still's disease with macrophage activation syndrome diagnosed and treated based on cytokine profiling: a case-based review.

Authors:  Ken Goda; Tsuneaki Kenzaka; Masahiko Hoshijima; Akihiro Yachie; Hozuka Akita
Journal:  Rheumatol Int       Date:  2019-09-20       Impact factor: 2.631

9.  Clinical significance of ¹⁸F-fluoro-dexoxyglucose positron emission tomography in patients with adult-onset Still's disease: report of two cases and review of literatures.

Authors:  Jung-Yoon Choe; Duck Soo Chung; Sung-Hoon Park; Hyun-Hee Kwon; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2009-09-24       Impact factor: 2.631

10.  Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis.

Authors:  Jeffrey H Ruth; Christy C Park; M Asif Amin; Charles Lesch; Hubert Marotte; Shiva Shahrara; Alisa E Koch
Journal:  Arthritis Res Ther       Date:  2010-06-16       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.